778
Views
0
CrossRef citations to date
0
Altmetric
Sepsis

Cost-effectiveness of intravenous resuscitation fluids in sepsis patients: a patient-level data analysis in Jordan

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 126-133 | Received 06 Oct 2023, Accepted 14 Dec 2023, Published online: 26 Dec 2023

References

  • Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi: 10.1164/rccm.201504-0781OC.
  • Napolitano LM. Sepsis 2018: definitions and guideline changes. Surg Infect. 2018;19(2):117–125. doi: 10.1089/sur.2017.278.
  • Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):775–787. doi: 10.1001/jama.2016.0289.
  • Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858–873. doi: 10.1097/01.ccm.0000117317.18092.e4.
  • Leisman DE, Doerfler ME, Schneider SM, et al. Predictors, prevalence, and outcomes of early crystalloid responsiveness among initially hypotensive patients with sepsis and septic shock. Crit Care Med. 2018;46(2):189–198. doi: 10.1097/CCM.0000000000002834.
  • Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of intensive care medicine. Intensive Care Med. 2014;40(12):1795–1815. doi: 10.1007/s00134-014-3525-z.
  • Casey JD, Brown RM, Semler MW. Resuscitation fluids. Curr Opin Crit Care. 2018;24(6):512–518. doi: 10.1097/MCC.0000000000000551.
  • Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. doi: 10.1097/CCM.0000000000005337.
  • Melia D, Post B. Human albumin solutions in intensive care: a review. J Intensive Care Soc. 2021;22(3):248–254. doi: 10.1177/1751143720961245.
  • Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412–1421. doi: 10.1056/NEJMoa1305727.
  • Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–2256.
  • Finfer S, McEvoy S, Bellomo R, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37(1):86–96.
  • Patel A, Laffan MA, Waheed U, et al. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561. doi: 10.1136/bmj.g4561.
  • Winters ME, Sherwin R, Vilke GM, et al. What is the preferred resuscitation fluid for patients with severe sepsis and septic shock? J Emerg Med. 2017;53(6):928–939. doi: 10.1016/j.jemermed.2017.08.093.
  • Zou Y, Ma K, Xiong JB, et al. Comparison of the effects of albumin and crystalloid on mortality among patients with septic shock: systematic review with meta-analysis and trial sequential analysis. Sao Paulo Med J. 2018;136(5):421–432. doi: 10.1590/1516-3180.2017.0285281017.
  • Guidet B, Mosqueda GJ, Priol G, et al. The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care. 2007;22(3):197–203. doi: 10.1016/j.jcrc.2006.11.005.
  • Guidet B, Ghout I, Ropers J, et al. Economic model of albumin infusion in septic shock: the EMAISS study. Acta Anaesthesiol Scand. 2020;64(6):781–788. doi: 10.1111/aas.13559.
  • Farrugia A, Bansal M, Balboni S, et al. Choice of fluids in severe septic patients – A cost-effectiveness analysis informed by recent clinical trials. Rev Recent Clin Trials. 2014;9(1):21–30. doi: 10.2174/1574887108666131213120816.
  • Tigabu BM, Davari M, Kebriaeezadeh A, et al. A cost-effectiveness analysis of albumin in septic shock: a patient-level data analysis. Clin Ther. 2019;41(11):2297–2307.e2. doi: 10.1016/j.clinthera.2019.08.023.
  • Global health expenditure database. 2023 [cited 2023 Oct 4]. http://apps.who.int/nha/database/
  • XE. 1 USD to JOD – Convert US Dollars to Jordanian Dinars. 2023. https://www.xe.com/.
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.
  • Woods BS, Sideris E, Palmer S, et al. Partitioned survival and state transition models for healthcare decision making in oncology: where are we now? Value Health. 2020;23(12):1613–1621. doi: 10.1016/j.jval.2020.08.2094.
  • Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. United Kingdom: Oxford University Press; 2006.
  • Liu P, Zhi D, Wang Y, et al. Effects of albumin supplements on in-hospital mortality in patients with sepsis or septic shock: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2022;2022:2384730. doi: 10.1155/2022/2384730.
  • Xu JY, Chen QH, Xie JF, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care. 2014;18(6):702. doi: 10.1186/s13054-014-0702-y.
  • Ge C, Peng Q, Chen W, et al. Association between albumin infusion and outcomes in patients with acute kidney injury and septic shock. Sci Rep. 2021;11(1):24083. doi: 10.1038/s41598-021-03122-0.
  • Zhou S, Zeng Z, Wei H, et al. Early combination of albumin with crystalloids administration might be beneficial for the survival of septic patients: a retrospective analysis from MIMIC-IV database. Ann Intensive Care. 2021;11(1):42. doi: 10.1186/s13613-021-00830-8.
  • Taylor C, Yang L, Finfer S, et al. An international comparison of the cost of fluid resuscitation therapies. Aust Crit Care. 2021;34(1):23–32. doi: 10.1016/j.aucc.2020.06.001.
  • World Bank WDI. GDP per capita (current US$) – Jordan. 2022 [cited 2023 Oct 12]. https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=JO.
  • World Bank WDI. Life expectancy at birth, total (years) – Jordan 2021 [cited 2023 Oct 12]. https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=JO.
  • Dong J, Chen R, Song X, et al. Quality of life and mortality in older adults with sepsis after one-year follow up: a prospective cohort study demonstrating the significant impact of frailty. Heart Lung. 2023;60:74–80. doi: 10.1016/j.hrtlng.2023.03.002.
  • Higgins AM, Brooker JE, Mackie M, et al. Health economic evaluations of sepsis interventions in critically ill adult patients: a systematic review. J Intensive Care. 2020;8(1):5. doi: 10.1186/s40560-019-0412-2.
  • Altawalbeh SM, Almestarihi EM, Khasawneh RA, et al. Clinical and economic outcomes associated with intravenous albumin fluid use in the intensive care unit: a retrospective cohort study. Expert Rev Pharmacoecon Outcomes Res. 2023;23(7):789–796. doi: 10.1080/14737167.2023.2215431.
  • Murthy S, Wunsch H. Clinical review: international comparisons in critical care – lessons learned. Crit Care. 2012;16(2):218. doi: 10.1186/cc11140.
  • Khanna AK, Labeau SO, McCartney K, et al. International variation in length of stay in intensive care units and the impact of patient-to-nurse ratios. Intensive Crit Care Nurs. 2022;72:103265. doi: 10.1016/j.iccn.2022.103265.
  • Wunsch H, Angus DC, Harrison DA, et al. Variation in critical care services across North america and Western Europe. Crit Care Med. 2008;36(10):2787–2793, e1-9. doi: 10.1097/CCM.0b013e318186aec8.
  • Fink RJ, Young A, Yanez ND, et al. Cohort study of albumin versus lactated ringer’s for postoperative cardiac surgery fluid resuscitation in the intensive care unit. Pharmacotherapy. 2018;38(12):1241–1249. doi: 10.1002/phar.2195.
  • Torbic H, Bauer SR, Militello M, et al. Evaluation of albumin 25% use in critically ill patients at a tertiary care medical center. Hosp Pharm. 2020;55(2):90–95. doi: 10.1177/0018578718823727.
  • Udeh CI, Wanek M, Udeh BL, et al. Application of unit-level cost transparency, education, enhanced audit, and feedback of anonymized peer ranking to promote judicious use of 25% albumin in critical care units. Hosp Pharm. 2020;55(3):154–162. doi: 10.1177/0018578719828341.
  • Vukovic M, Gvozdenovic BS, Rankovic M, et al. Can didactic continuing education improve clinical decision making and reduce cost of quality? Evidence from a case study. J Contin Educ Health Prof. 2015;35(2):109–118.
  • Arora V, Moriates C, Shah N. The challenge of understanding health care costs and charges. AMA J Ethics. 2015;17(11):1046–1052.
  • Tunis SL. A cost-effectiveness analysis to illustrate the impact of cost definitions on results, interpretations and comparability of pharmacoeconomic studies in the US. Pharmacoeconomics. 2009;27(9):735–744. doi: 10.2165/10899600-000000000-00000.